TargetMol

Prucalopride Succinate

Product Code:
 
TAR-T6958
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6958-1mL1 mL * 10 mM (in DMSO)£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6958-10mg10mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6958-25mg25mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6958-50mg50mg£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6958-100mg100mg£163.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6958-200mg200mg£216.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Prucalopride is a selective, high affinity 5-HT4 receptor agonist, inhibiting human 5-HT(4a) and 5-HT(4b) receptor with Ki value of 2.5 nM and 8 nM, respectively.
CAS:
179474-85-2
Formula:
C22H32ClN3O7
Molecular Weight:
485.96
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.9924
SMILES:
OC(=O)CCC(O)=O.COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(N)c2CCOc12
Target:
5-HT Receptor

References

Briejer MR, et al. Neurogastroenterol Motil, 2001, 13(5), 465-472. Priem E, et al. Neuropharmacology, 2012, 62(5-6), 2126-2135. Priem EK, et al. Eur J Pharmacol, 2013, 705(1-3), 156-163. Briejer MR, et al. Eur J Pharmacol, 2001, 423(1), 71-83.